Table 5: Open in new tab Reoperation...

	Univariate	Multivariable
Male sex	0.60	0.53	0.12–3.04
Age	1.01	0.77	0.94–1.08
LVEF	1.08	0.040	1.00–1.17	1.07	0.098	0.99–1.17
LVEDD	1.41	0.13	0.91–2.19
Leaflet fibrosis	4.46	0.067	0.90–22.10	4.11	0.083	0.83–20.35
Rheumatic fever	0.80	0.77	0.18–3.60
Leaflet calcification	4.78	0.18	0.48–47.49
sPAP	1.01	0.77	0.95–1.07
NYHA >2	0.96	0.96	0.21–4.44
AF	3.61	0.13	0.68–19.09

	Univariate	Multivariable
Male sex	0.60	0.53	0.12–3.04
Age	1.01	0.77	0.94–1.08
LVEF	1.08	0.040	1.00–1.17	1.07	0.098	0.99–1.17
LVEDD	1.41	0.13	0.91–2.19
Leaflet fibrosis	4.46	0.067	0.90–22.10	4.11	0.083	0.83–20.35
Rheumatic fever	0.80	0.77	0.18–3.60
Leaflet calcification	4.78	0.18	0.48–47.49
sPAP	1.01	0.77	0.95–1.07
NYHA >2	0.96	0.96	0.21–4.44
AF	3.61	0.13	0.68–19.09

Table 5:

Reoperation risk analysis with the Fine–Gray model

	Univariate			Multivariable
	SHR	P-value	95% CI	SHR	P-value	95% CI
Male sex	0.60	0.53	0.12–3.04
Age	1.01	0.77	0.94–1.08
LVEF	1.08	0.040	1.00–1.17	1.07	0.098	0.99–1.17
LVEDD	1.41	0.13	0.91–2.19
Leaflet fibrosis	4.46	0.067	0.90–22.10	4.11	0.083	0.83–20.35
Rheumatic fever	0.80	0.77	0.18–3.60
Leaflet calcification	4.78	0.18	0.48–47.49
sPAP	1.01	0.77	0.95–1.07
NYHA >2	0.96	0.96	0.21–4.44
AF	3.61	0.13	0.68–19.09

	Univariate			Multivariable
	SHR	P-value	95% CI	SHR	P-value	95% CI
Male sex	0.60	0.53	0.12–3.04
Age	1.01	0.77	0.94–1.08
LVEF	1.08	0.040	1.00–1.17	1.07	0.098	0.99–1.17
LVEDD	1.41	0.13	0.91–2.19
Leaflet fibrosis	4.46	0.067	0.90–22.10	4.11	0.083	0.83–20.35
Rheumatic fever	0.80	0.77	0.18–3.60
Leaflet calcification	4.78	0.18	0.48–47.49
sPAP	1.01	0.77	0.95–1.07
NYHA >2	0.96	0.96	0.21–4.44
AF	3.61	0.13	0.68–19.09

AF: atrial fibrillation; LVEDD: left ventricular end-systolic diameter; LVEF: left ventricular ejection fraction; NYHA: New York Heart Association; SHR: subdistribution hazard ratio; sPAP: systolic pulmonary artery pressure; TR: tricuspid regurgitation.

This Feature Is Available To Subscribers Only